Brind.

Stuart Rich has been appointed Chief Medical Officer at Tenax Therapeutics.

2 reports, 2 independent Updated Oct 29
Gone quiet
Reports
2
Developments
2
Repetition
0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Stuart Rich has been appointed Chief Medical Officer at Tenax Therapeutics.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Tenax Therapeutics is listed on the Nasdaq stock exchange.1 source
  2. Stuart Rich is the Chief Medical Officer at Tenax Therapeutics.1 source

Keep exploring

The entities involved

  • Stuart Rich

    researcher (ORCID 0000-0002-2233-1789)

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • prnewswire.com
  • GlobeNewswireTenax Therapeutics to Participate in the Cantor Global Healthcare Conference 2025 CHAPEL HILL, N.C., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax Therapeutics” or